Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (38)

2024

  1. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

    Frontiers in Immunology, Vol. 15

  2. Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial

    Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 702-710

2023

  1. Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

    Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46

  2. First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 11, pp. 581-585

  3. Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis

    Computer Methods and Programs in Biomedicine, Vol. 242

  4. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

  5. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 461-466

2022

  1. A Tool to Distinguish Viral from Bacterial Pneumonia

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 1, pp. 31-36

  2. Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 5, pp. 225-228

  3. Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children

    Frontiers in Immunology, Vol. 13

  4. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  5. Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy

    Frontiers in immunology, Vol. 13, pp. 860418

  6. Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

    Journal of Pediatrics, Vol. 241, pp. 126-132.e3

  7. Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial

    Trials, Vol. 23, Núm. 1

  8. Factors associated with late presentation for HIV care in adolescents in Spain

    HIV Medicine, Vol. 23, Núm. 11, pp. 1195-1201

  9. Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort

    European Journal of Pediatrics, Vol. 181, Núm. 2, pp. 589-598

  10. Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS

    PloS one, Vol. 17, Núm. 10, pp. e0276116

  11. Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children

    Acta Paediatrica, International Journal of Paediatrics, Vol. 111, Núm. 10, pp. 1974-1977

  12. Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence

    BMC public health, Vol. 22, Núm. 1, pp. 1312

  13. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population

    Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058